Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topoxy vs Topicorte in Scalp Psoriasis
NCT02749656Phase 3Unknown
- Sponsor
- Siriraj Hospital
- Start
- Jan 2016
- Primary completion
- Jan 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Topoxy in psoriasis (3 arms), sponsored by Siriraj Hospital. Primary endpoint: Investigator's Global Assessment score at 8 weeks. Status: unknown.
02
Drugs
Topoxy
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT02749656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02749656.